These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28266780)

  • 1. Recent advances in genetic modification of adenovirus vectors for cancer treatment.
    Yamamoto Y; Nagasato M; Yoshida T; Aoki K
    Cancer Sci; 2017 May; 108(5):831-837. PubMed ID: 28266780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
    Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
    Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
    Yamamoto Y; Hiraoka N; Goto N; Rin Y; Miura K; Narumi K; Uchida H; Tagawa M; Aoki K
    J Control Release; 2014 Oct; 192():284-93. PubMed ID: 25108153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in oncolytic adenovirus therapies for cancer.
    Rosewell Shaw A; Suzuki M
    Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts in Oncolytic Adenovirus Therapy.
    Mantwill K; Klein FG; Wang D; Hindupur SV; Ehrenfeld M; Holm PS; Nawroth R
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Targeting of Oncolytic Adenoviruses Using Bispecific Adapter Proteins.
    Niemann J; Kühnel F
    Methods Mol Biol; 2020; 2058():31-49. PubMed ID: 31486030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
    Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
    Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy.
    Wu C; Wei FK; Xu ZY; Wen RM; Chen JC; Wang JQ; Mao LJ
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):866-872. PubMed ID: 34719211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5
    Davies JA; Marlow G; Uusi-Kerttula HK; Seaton G; Piggott L; Badder LM; Clarkson RWE; Chester JD; Parker AL
    Viruses; 2021 May; 13(5):. PubMed ID: 34066836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
    Lucas T; Benihoud K; Vigant F; Schmidt CQ; Wortmann A; Bachem MG; Simmet T; Kochanek S
    PLoS One; 2015; 10(2):e0117254. PubMed ID: 25692292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic viruses: adenoviruses.
    Niemann J; Kühnel F
    Virus Genes; 2017 Oct; 53(5):700-706. PubMed ID: 28702840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chapter four--Design of improved oncolytic adenoviruses.
    Alemany R
    Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity.
    Garofalo M; Iovine B; Kuryk L; Capasso C; Hirvinen M; Vitale A; Yliperttula M; Bevilacqua MA; Cerullo V
    Mol Cancer Ther; 2016 Apr; 15(4):651-60. PubMed ID: 26861248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.
    Kim J; Li Y; Kim SW; Lee DS; Yun CO
    Biomaterials; 2013 Jun; 34(19):4622-31. PubMed ID: 23541109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
    Jönsson F; Hagedorn C; Kreppel F
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ad5
    Uusi-Kerttula H; Davies JA; Thompson JM; Wongthida P; Evgin L; Shim KG; Bradshaw A; Baker AT; Rizkallah PJ; Jones R; Hanna L; Hudson E; Vile RG; Chester JD; Parker AL
    Clin Cancer Res; 2018 Sep; 24(17):4215-4224. PubMed ID: 29798908
    [No Abstract]   [Full Text] [Related]  

  • 19. Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy.
    Hagedorn C; Kreppel F
    Hum Gene Ther; 2017 Oct; 28(10):820-832. PubMed ID: 28854810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.
    Yoon AR; Hong J; Kim SW; Yun CO
    Expert Opin Drug Deliv; 2016 Jun; 13(6):843-58. PubMed ID: 26967319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.